IP footprint
The TLO is entrusted with managing IP for numerous 丁香园AV innovators in a diverse number of industry sectors.
1300+
IP Assets under TLO management
$1.5M
licensing revenue in last 12 months
7+
startups formed in last 12 months
Innovation within the 丁香园AV ecosystem
Much of the innovation happening within the 丁香园AV ecosystem is taking place in the following sectors: clean tech, electronics, life sciences and medical devices.
This chart represents the diversity of the TLO IP portfolio with respect to major industry sectors.
British Columbia has the fastest-growing life sciences sector in Canada. TLO is supporting a wide Life Sciences portfolio including: 1. Dual-Action EP4 Agonist鈥擝isphosphonate Conjugates (Robert Young); 2. Reagents for Synthesizing Nucleosides (Robert Britton); and 3. Selective glcosidase inhibitors and uses thereof (David Vocadlo).
The TLO's IP portfolio within the Electronics sector embodies pioneering innovation that is shaping the trajectory of future technology. These technologies include: 1. Magnetic Coupling Layers STT-RAM (Erol Girt); 2. Hyperjump - VR Navigation Solution (Bernhard Riecke); and 3. Yagiz Aksoy 鈥� AI Intrinsic Image Decomposition via Ordinal Shading (Yagiz Aksoy).
TLO has made cleantech one of its innovation priorities, and is home to world-leading translational researchers Included within the TLO鈥檚 cleantech portfolio are: 1. Hydrogen Electrolyzer AEM/PEM membranes (Steven Holdcroft); 2. Hydrogen Embrittlement Resistant Coating technology (Sami Khan); and 3. Honey Bee Varroa Mite Acaricides (Erika Plettner).
TLO is actively fostering innovation within its Medical Devices portfolio, envisioning a transformed approach to patient care and striving for a healthier future. Portfolio includes: 1. Ultrasensitive and Rapid Cytokine Diode Sensor Based on Asymmetric 2D crystals for Health Applications (Michael Adachi) and 2. Electrical Sensor and Blood Pressure Monitoring System (Woo Soo Kim).